Skip to content

The Effectiveness of Sublingual or Oral Administration Misoprostol for Cervical Ripening before Manual Vacuum Aspiration in First Trimester Termination of Pregnancy: Randomized Controlled Trial

The Effectiveness of Sublingual or Oral Administration Misoprostol for Cervical Ripening before Manual Vacuum Aspiration in First Trimester Termination of Pregnancy: Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20140427001
Enrollment
Unknown
Registered
2014-04-27
Start date
2013-11-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First trimester termination of pregnancy The effectiveness of Misoprostol for cervical preparation before manual vacuum aspiration first trimester abortion misoprostol cervical dilatation manual vacuum aspiration

Interventions

Sublingual group (SG) received a 400 &#181
g misoprostol sublingually plus on an oral placebo two hours prior to manual vacuum aspiration.,Oral group (OG) received a 400 &#181
g misoprostol orally and a sublingual placebo two hours prior manual vacuum aspiration.
Active Comparator Drug,Active Comparator Drug
sublingual misoprostol,oral misoprostol

Sponsors

Faculty of medicine, Thammasat University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: A singleton intrauterine pregnancy equal or less than 12 weeks gestational age with a diagnosis of early pregnancy failure blighted ovum anembryonic gestation and embryonic death no cardiac activity visible on TVS when the embryo measures 5 mm or more in length The gestational age was verified by a reliable menstrual history and confirmed by physical or ultrasound examination

Exclusion criteria

Exclusion criteria: A history of misoprostol allergy anticoagulant usage clinical coagulopathy bleeding disorder hypertension chronic illness active pelvic inflammatory disease inevitable and incomplete abortion

Design outcomes

Primary

MeasureTime frame
cervical dilatation was measured prior to Manual Vacuum Aspiration The cervical width was measured prior to Manual Vacuum Aspiration cervical width was measured by largest Hegar’s dilators that pass through cervix without resistance

Secondary

MeasureTime frame
pain scores and patient satisfactions after finished manual vacuum aspiration visual analogue 10cm-scale with zero to 10

Countries

Thailand

Contacts

Public ContactDensak pongrojpaw

Department of Obstetrics and Gynaecology, Faculty of medicine, Thammasat University

Pongrojpaw@hotmail.com+662-926-9343

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026